A Phase I Dose-Escalation and Pharmacokinetic Study of TrasGEX in Patients With Locally Advanced or Metastatic HER-2-positive Cancer
Phase of Trial: Phase I
Latest Information Update: 03 Jun 2014
At a glance
- Drugs Trastuzumab (Primary)
- Indications Solid tumours
- Focus Adverse reactions; First in man; Pharmacokinetics
- Sponsors Glycotope
- 01 Dec 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 03 Jan 2013 Planned End Date changed from 1 Jun 2012 to 1 Jun 2013 as reported by ClinicalTrials.gov.
- 08 Aug 2011 New trial record